A Trimodal Prehabilitation Study for Patients Undergoing Major Abdominal Surgery
2019年8月16日 更新者:Shira Baram
Trimodal Prehabilitation Programme Using Smart Watches and Mobile Applications in Patients Undergoing Major Abdominal Surgery: a Randomised Controlled Pilot Study
Prehabilitation programmes have the potential to reduce post-operative complications following abdominal cancer surgery by improving pre-operative fitness levels.
Home-based prehabilitation programmes may be more cost effective than hospital-based programmes, but have issues with low compliance.
The aims of our study are to assess whether mobile technologies such as smart watches and smartphone applications improve compliance with home-based prehabilitation programmes and to assess the effects of prehabilitation on pre-operative fitness levels in patients due to undergo major abdominal cancer surgery.
研究概览
详细说明
30 patients due to undergo major abdominal cancer surgery at The Christie NHS Foundation Trust will be enrolled to a pilot randomised controlled trial.
They will randomised to either a home-based trimodal prehabilitation programme, delivered by the use of FitBit Smart Watches and Smartphone applications, or a control group who will receive a FitBit for physical activity monitoring only, for a period of 2-6 weeks prior to surgery.
The prehabilitation programme will include exercise, nutritional, and psychological components.
Study outcomes will include 6MWT (6-minute walk test), HADS (hospital anxiety and depression score), steps per day, length of stay post-operatively, and post-operative complications.
研究类型
介入性
注册 (预期的)
30
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
- 姓名:Shira Baram
- 电话号码:0161 918 2098
- 邮箱:shira.baram@christie.nhs.uk
学习地点
-
-
-
Manchester、英国
- 招聘中
- The Christie NHS Foundation Trust
-
接触:
- Shira Baram
- 电话号码:01619182098
- 邮箱:shira.baram@christie.nhs.uk
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 至 80年 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- be aged 18 years or over
- be able to consent to participate in the prehabilitation programme
- be undergoing major abdominal cancer surgery (including, but not limited to, cytoreductive surgery with hyperthermic intraperitoneal chemotherapy)
- have at least 2 weeks to their operation date
- be able to understand written and spoken English
Exclusion Criteria:
- patients have any health conditions which will prevent them from safely taking part in a home-based exercise programme. For example, but not limited to, patients who have recently (within the past 3 months) had a myocardial infarction or a stroke or patients who have end-stage renal disease but are not on dialysis. We will use the "Safety Reference Guide to support exercise services in people with cancer" in The Lancet published paper "Exercise as part of routine cancer care"(5) to aid the screening of patients suitability.
- they have any bone metastasis
- are already active users of a FitBit device
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:基础科学
- 分配:随机化
- 介入模型:顺序分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
其他:Prehabilitation
These participants will receive a home based prehabilitation programme for a period of 2-6 weeks prior to surgery and will be provided with a Fitbit Charge 2.
|
Each participant will receive a Fitbit.
The Prehabilitaiton Group will receive a Fitbit Charge 2 and they will be able to review their progress on this and be required to increase their exercise activity and input information and data about the exercise they have completed each day during their participation in the study.
The Control group will receive a Fitbit Flex and will not be required to review any of their activity or input any data and will be encouraged to continue with their daily activity rates i.e. not to change.
|
其他:Control
These participants will receive a Fitbit Flex and told to continue with their every day activity levels for a period of 2-6 weeks prior to surgery
|
Each participant will receive a Fitbit.
The Prehabilitaiton Group will receive a Fitbit Charge 2 and they will be able to review their progress on this and be required to increase their exercise activity and input information and data about the exercise they have completed each day during their participation in the study.
The Control group will receive a Fitbit Flex and will not be required to review any of their activity or input any data and will be encouraged to continue with their daily activity rates i.e. not to change.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Quantitative data collected via a Fitbit
大体时间:Each participant will be monitored for a period of 2-6 weeks pre surgery
|
Data will be collected to determine the number of participants whose physical activity increased and by how much during the study
|
Each participant will be monitored for a period of 2-6 weeks pre surgery
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Qualitative data collected by questionnaire
大体时间:Each participant will be monitored for a period of 2-6 weeks pre surgery
|
Qualitative data will be collected from participants to identify their experience of the study
|
Each participant will be monitored for a period of 2-6 weeks pre surgery
|
Quantitative data associated with participants weight at the start and end of the research intervention
大体时间:Each participant will be monitored for a period of 2-6 weeks pre surgery
|
Participants weight will be measured in kilograms at the start of their participation and then prior to surgery to determine if they were able to either maintain their weight or gain weight
|
Each participant will be monitored for a period of 2-6 weeks pre surgery
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
赞助
调查人员
- 首席研究员:Omer Aziz、The Christie NHS Foundation Trust
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2019年5月14日
初级完成 (预期的)
2019年12月28日
研究完成 (预期的)
2019年12月28日
研究注册日期
首次提交
2019年7月15日
首先提交符合 QC 标准的
2019年8月5日
首次发布 (实际的)
2019年8月6日
研究记录更新
最后更新发布 (实际的)
2019年8月20日
上次提交的符合 QC 标准的更新
2019年8月16日
最后验证
2019年8月1日
更多信息
与本研究相关的术语
其他研究编号
- 19_SURG_19
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
不
IPD 计划说明
Data will not currently be shared with researchers outside of the study team
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.